Biomark Diagnostics Inc. (CSE: BUX)
Canada
· Delayed Price · Currency is CAD 0.220
-0.005 (-2.22%)
Dec 2, 2024, 4:00 PM EST
Biomark Diagnostics Revenue
Biomark Diagnostics had revenue of 38.35K CAD in the quarter ending September 30, 2024, a decrease of -8.97%. This brings the company's revenue in the last twelve months to 158.01K, down -0.31% year-over-year. In the fiscal year ending March 31, 2024, Biomark Diagnostics had annual revenue of 163.22K with 6.34% growth.
Revenue (ttm)
158.01K
Revenue Growth
-0.31%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
16.80M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries Inc. | 1.51B |
| Trulieve Cannabis Corp. | 1.58B |
| Cresco Labs Inc. | 981.27M |
| Grown Rogue International Inc. | 28.83M |
| Planet 13 Holdings Inc. | 147.38M |
| Ayr Wellness Inc. | 627.53M |
| Jushi Holdings Inc. | 350.48M |
| MariMed Inc. | 213.26M |